P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

by Hecht FM, Barbour JD, Nixon DF, Levy JA, Jha AR, Ho T, Tan QX, Epling L, Sinclair E, Ndhlovu L
Published 2009-10-01

Randomized controlled trial of a positive affect intervention to reduce stress in people newly diagnosed with HIV; protocol and design for the IRISS study

by Moskowitz JT, Carrico AW, Cohn MA, Duncan LG, Bussolari C, Layous K, Hult JR, Brousset A, Cotten P, Maurer S, Pietrucha ME, Acree M, Wrubel J, Johnson MO, Hecht FM, Folkman S
Published 2014-09-01